Jefferies analyst Robert Dickerson reiterated a Sell rating on The Hershey Company (HSY – Research Report) today and set a price target of ...
Jefferies maintains a Buy rating on JB Pharma citing strong CDMO growth potential and a 34% upside. Know more about it.
Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.
FY25 net profit rose 33% YoY to Rs 497 crore, with revenue increasing 34% to Rs 4,657 crore. Sequentially, profit grew 47%, ...
Jefferies analyst Julien Dormois maintained a Hold rating on Demant (WILLF – Research Report) today and set a price target of DKK265.00. The ...
Jefferies reaffirms 'Buy' on ONGC, citing growth from BP partnership and policy changes. Target price: Rs 375. Read more now.
Brent Thill, Jefferies, joins 'Fast Money' to talk Palantir and where the stock goes from here after record run.
These healthcare REITs are rated Buy at Jefferies and make sense now for investors seeking dependable passive income and a ...
Jefferies expects the debt requirements to peak in fiscal 2025-27 at 1.4 times net debt versus one times in the previous ...
Jefferies analysts adjusted their outlook on InterDigital Inc. (NASDAQ:IDCC), raising the price target to $210 from the previous $195, while maintaining a Hold rating on the company's shares. The ...
President Donald Trump announced 25% tariffs on all goods imported from Canada and Mexico and a 10% levy on China on Saturday ...
Investing.com -- SSAB (ST: SSABa )'s share price saw a notable recovery after investment bank Jefferies upgraded its rating ...